Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Herpes. 2007.
PMID: 17939892
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1957 | 1 |
| 1961 | 1 |
| 1969 | 1 |
| 1975 | 1 |
| 1977 | 3 |
| 1978 | 3 |
| 1980 | 2 |
| 1981 | 2 |
| 1982 | 1 |
| 1983 | 7 |
| 1984 | 5 |
| 1985 | 3 |
| 1986 | 1 |
| 1987 | 3 |
| 1988 | 6 |
| 1989 | 2 |
| 1990 | 4 |
| 1991 | 6 |
| 1992 | 6 |
| 1993 | 6 |
| 1994 | 9 |
| 1995 | 6 |
| 1996 | 5 |
| 1997 | 9 |
| 1998 | 10 |
| 1999 | 6 |
| 2000 | 13 |
| 2001 | 4 |
| 2002 | 11 |
| 2003 | 5 |
| 2004 | 18 |
| 2005 | 12 |
| 2006 | 7 |
| 2007 | 18 |
| 2008 | 20 |
| 2009 | 19 |
| 2010 | 14 |
| 2011 | 25 |
| 2012 | 30 |
| 2013 | 26 |
| 2014 | 23 |
| 2015 | 33 |
| 2016 | 27 |
| 2017 | 23 |
| 2018 | 34 |
| 2019 | 22 |
| 2020 | 21 |
| 2021 | 41 |
| 2022 | 42 |
| 2023 | 48 |
| 2024 | 48 |
| 2025 | 65 |
| 2026 | 41 |
Search Results
737 results
Results by year
Citations
6
articles
found by citation matching
[Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster].
Kansenshogaku Zasshi. 1995.
PMID: 7594784
Japanese.
The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
PLoS One. 2017.
PMID: 28545047
Free PMC article.
Search results
Page 1
Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
New Microbiol. 2018 Apr;41(2):95-105. Epub 2018 Mar 2.
New Microbiol. 2018.
PMID: 29498740
Free article.
Review.
Varicella-zoster virus (VZV) is the etiologic agent of varicella (chicken pox), a childhood exanthematic disease that develops as a result of primary infection, and zoster (shingles), caused by reactivation of the virus persisting in a la …
Varicella-zoster virus (VZV) is the etiologic agent of varicella (chicken pox), a childhood exanthematic disease …
Varicella zoster virus.
J Am Acad Dermatol. 1999 Jul;41(1):1-14; quiz 15-6. doi: 10.1016/s0190-9622(99)70398-1.
J Am Acad Dermatol. 1999.
PMID: 10411403
Review.
Because of its ability to produce two clinically distinct disease entities (chickenpox and shingles), varicella zoster virus (VZV) is an unusual etiologic agent. Although in the past viral exanthems were mostly only of academic interest to the practitioner, t …
Because of its ability to produce two clinically distinct disease entities (chickenpox and shingles), varicella zoster viru …
Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial.
JAMA Ophthalmol. 2025 Apr 1;143(4):269-276. doi: 10.1001/jamaophthalmol.2024.6114.
JAMA Ophthalmol. 2025.
PMID: 40048183
Free PMC article.
Clinical Trial.
IMPORTANCE: High-quality evidence regarding suppressive valacyclovir treatment in herpes zoster ophthalmicus (HZO) is necessary to guide care. OBJECTIVE: To determine whether suppressive valacyclovir compared with placebo delays the occurrence of new or worsening st …
IMPORTANCE: High-quality evidence regarding suppressive valacyclovir treatment in herpes zoster ophthalmicus (HZO) is necessar …
Herpes zoster recurrence, and safety and immunogenicity of the recombinant zoster vaccine in adults aged 50 years with a history of herpes zoster: A phase 3, randomized controlled trial.
J Infect. 2025 Sep;91(3):106573. doi: 10.1016/j.jinf.2025.106573. Epub 2025 Aug 6.
J Infect. 2025.
PMID: 40780591
Free article.
Clinical Trial.
OBJECTIVES: To assess HZ recurrence (primary objective), safety and immunogenicity of the recombinant zoster vaccine (RZV) in adults with prior HZ. METHODS: This phase 3, observer-blind, multi-country study (NCT04091451) enrolled participants 50 years with one resolved HZ …
OBJECTIVES: To assess HZ recurrence (primary objective), safety and immunogenicity of the recombinant zoster vaccine (RZV) in adults …
NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention.
Ann Intern Med. 1988 Feb;108(2):221-37. doi: 10.7326/0003-4819-108-2-221.
Ann Intern Med. 1988.
PMID: 2829675
Review.
During the last 10 years, there have been major advances in the understanding of varicella-zoster virus and the diseases it causes. The molecular biology of the virus is being unraveled with the aid of new molecular technologies. Varicella, usua …
During the last 10 years, there have been major advances in the understanding of varicella-zoster virus and the disease …
Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Scand J Infect Dis Suppl. 1991;80:69-74.
Scand J Infect Dis Suppl. 1991.
PMID: 1666447
Review.
Varicella-zoster virus (VZV) causes significant morbidity and even mortality in immunocompromised patients. Varicella has more serious consequences than herpes zoster, although zoster is more common. ...
Varicella-zoster virus (VZV) causes significant morbidity and even mortality in immunocompromised patients. Varicell …
Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.
Am J Med. 1988 Aug 29;85(2A):68-73.
Am J Med. 1988.
PMID: 3044096
Review.
Untreated immunocompromised adults with herpes zoster shed virus for longer (7.0 days) than otherwise normal adults (5.3 days). ...The major future challenge is to find an optimal way to treat varicella zoster virus infections with oral f …
Untreated immunocompromised adults with herpes zoster shed virus for longer (7.0 days) than otherwise normal adults (5. …
Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.
N Engl J Med. 1983 Dec 8;309(23):1434-40. doi: 10.1056/NEJM198312083092306.
N Engl J Med. 1983.
PMID: 6195526
Review.
New knowledge of the relationship between the varicella-zoster virus and its host suggests a heretofore unappreciated dynamic pattern. ...Thus, the therapeutic use of immunosuppressive or cytotoxic substances increases the morbidity and mortality associated w …
New knowledge of the relationship between the varicella-zoster virus and its host suggests a heretofore unappreciated d …
Natural history and treatment of herpes zoster.
J Pain. 2008 Jan;9(1 Suppl 1):S3-9. doi: 10.1016/j.jpain.2007.10.002.
J Pain. 2008.
PMID: 18166460
Free article.
Review.
Herpes zoster begins with reactivation of varicella zoster virus in dorsal root or cranial nerve ganglia, which is often accompanied by a prodrome of dermatomal pain or abnormal sensations. Varicella zoster virus spreads in …
Herpes zoster begins with reactivation of varicella zoster virus in dorsal root or cranial nerve ganglia, …
[Reactivation of herpes zoster infection by varicella-zoster virus].
Med Pregl. 1999 Mar-May;52(3-5):125-8.
Med Pregl. 1999.
PMID: 10518396
Review.
Croatian.
HISTORY: There has been considerable interest in varicella-zoster virus in the middle of the twentieth century. Virus isolation in 1958 had made it possible to find out the complete DNA sequence of the varicella-zoster virus …
HISTORY: There has been considerable interest in varicella-zoster virus in the middle of the twentieth century. …
Cite